Showing results (41-50 of 130) with videos related to
Sort By:
Pageof 13
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 2, 1999
NHS-MAS3: a bifunctional chelator alternative to NHS-MAG3F Chang, T Qu, M Rusckowski, et al.Nuclear Medicine Communications|July 1, 1992
The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reductionG Mardirossian, C Wu, M Rusckowski, et al.Cancer|December 24, 1997
Early results in the irrational design of new bifunctional chelatorsF Chang, M Rusckowski, T Qu, et al.The Journal of Peptide Research : Official Journal of the American Peptide Society|December 24, 1997
Technetium-99m labeled epidermal growth factor-tumor imaging in miceM Rusckowski, T Qu, F Chang, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 17, 2000
Sentinel node localization by lymphoscintigraphy: a reliable technique with widespread applicationsG Paganelli, C De Cicco, M ChinolJournal of Immunological Methods|February 11, 1985
A simple in vitro method of screening panels of monoclonal antibodies for tumor bindingM Rusckowski, P W Doherty, F Virzi, et al.Journal of Immunological Methods|December 16, 1983
The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved methodD J Hnatowich, R L Childs, D Lanteigne, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1975
Three-dimensional reconstruction of lung perfusion image with positron detectionD A Chesler, C Hales, D J Hnatowich, et al.Nuclear Medicine and Biology|July 1, 1997
Preparation and use of NHS-MAG3 for technetium-99m labeling of DNAP Winnard, F Chang, M Rusckowski, et al.Nuclear Medicine and Biology|November 1, 1994
Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?D J Hnatowich, F Virzi, M Fogarasi, et al.Pageof 13